Metraipolis › archive › dc_151ce8584543

The SnaFab versus the Razi antivenom for treatment of snakebite envenomation: A randomized, double-blind (investigator and victims), active controlled,… — Europe PMC PMID:41284702

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41284702
DOI
10.1371/journal.pgph.0004281
License (as archived)
solo-consultazione
Archived
2026-11-08T07:59:13.002Z
SHA-256 of the archived text
a70a56ce5302b08ffc81900d2f04b9a5d2030bb8554493e9c9b5b1693b783324
Stable URL of this page
https://metraipolis.com/documento/dc_151ce8584543

How to cite

The SnaFab versus the Razi antivenom for treatment of snakebite envenomation: A randomized, double-blind (investigator and victims), active controlled,… — Europe PMC PMID:41284702 — Europe PMC (en), https://europepmc.org/article/MED/41284702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_151ce8584543 (Metraipolis archive dc_151ce8584543, sha256 a70a56ce5302b08ffc81900d2f04b9a5d2030bb8554493e9c9b5b1693b783324)
BibTeX
@misc{dc151ce8584543,
  title = {The SnaFab versus the Razi antivenom for treatment of snakebite envenomation: A randomized, double-blind (investigator and victims), active controlled,… — Europe PMC PMID:41284702},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41284702},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_151ce8584543; sha256 a70a56ce5302b08ffc81900d2f04b9a5d2030bb8554493e9c9b5b1693b783324},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41284702. Agents can read the archived copy with the MCP tool read_document.